Exhibit 99.1
 UROPLASTY REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER FY2011
 Global Sales increase 9%; U.S. Macroplastique sales grow 50%
Sales to U.S. customers up 23%
Conference call today at 3:30 p.m. CT
 MINNEAPOLIS, MN, October 27, 2010
    Fiscal Second Quarter and First Half Results for the Period Ended September 30, 2010




---



##### 



Conference Call




---



##### 



About Uroplasty, Inc.
   Forward-Looking Information
  For Further Information:
 Uroplasty, Inc.
    
    EVC GroupDavid Kaysen, President and CEO, or
    
    Doug Sherk/Jenifer Kirtland (Investors)Medi Jiwani, Vice President, CFO, and
    
    415.896.6820Treasurer
    
    Chris Gale (Media)952.426.6140
    
    646.201.5431




---



##### 



Three Months Ended
    
    
    Six Months EndedSeptember 30,
    
    
    September 30,2010
    
    
    2009
    
    
    2010
    
    
    2009Net sales
    
    $
    3,244,823
    
    
    $
    2,986,475
    
    
    $
    6,280,322
    
    
    $
    5,812,404Cost of goods sold
    
    
    594,469
    
    
    
    535,074
    
    
    
    1,105,165
    
    
    
    1,087,044Gross profit
    
    
    2,650,354
    
    
    
    2,451,401
    
    
    
    5,175,157
    
    
    
    4,725,360Operating expensesGeneral and administrative
    
    
    897,368
    
    
    
    713,040
    
    
    
    1,747,685
    
    
    
    1,561,591Research and development
    
    
    472,008
    
    
    
    435,898
    
    
    
    872,637
    
    
    
    963,713Selling and marketing
    
    
    2,017,420
    
    
    
    1,968,054
    
    
    
    4,005,946
    
    
    
    4,025,342Amortization
    
    
    210,682
    
    
    
    211,503
    
    
    
    421,450
    
    
    
    423,3163,597,478
    
    
    
    3,328,495
    
    
    
    7,047,718
    
    
    
    6,973,962Operating loss
    
    
    (947,124
    )
    
    
    (877,094
    )
    
    
    (1,872,561
    )
    
    
    (2,248,602
    )Other income (expense)Interest income
    
    
    17,999
    
    
    
    24,230
    
    
    
    31,627
    
    
    
    55,629Interest expense
    
    
    (1,938
    )
    
    
    (1,788
    )
    
    
    (3,885
    )
    
    
    (9,694
    )Foreign currency exchange gain (loss)
    
    
    10,574
    
    
    
    (7,365
    )
    
    
    12,364
    
    
    
    (14,697
    )Other, net
    
    
    
    
    
    
    2,000
    
    
    
    (192
    )
    
    
    (183
    )26,635
    
    
    
    17,077
    
    
    
    39,914
    
    
    
    31,055Loss before income taxes
    
    
    (920,489
    )
    
    
    (860,017
    )
    
    
    (1,832,647
    )
    
    
    (2,217,547
    )Income tax expense
    
    
    2,183
    
    
    
    14,642
    
    
    
    19,333
    
    
    
    22,887Net loss
    
    $
    (922,672
    )
    
    $
    (874,659
    )
    
    $
    (1,851,980
    )
    
    $
    (2,240,434
    )Basic and diluted loss per common share
    
    $
    (0.05
    )
    
    $
    (0.06
    )
    
    $
    (0.11
    )
    
    $
    (0.15
    )Weighted average common shares
outstanding:Basic and diluted
    
    
    19,088,249
    
    
    
    14,946,540
    
    
    
    17,207,957
    
    
    
    14,942,179




---



##### 



September 30, 2010
    
    
    March 31, 2010AssetsCurrent assets:Cash and cash equivalents & short-term investments
    
    $
    21,387,687
    
    
    $
    5,811,269Accounts receivable, net
    
    
    1,492,279
    
    
    
    1,287,440Inventories
    
    
    472,584
    
    
    
    341,497Income tax receivable
    
    
    
    
    
    
    23,820Other
    
    
    318,808
    
    
    
    237,321Total current assets
    
    
    23,671,358
    
    
    
    7,701,347Property, plant, and equipment, net
    
    
    1,186,372
    
    
    
    1,230,771Intangible assets, net
    
    
    2,122,945
    
    
    
    2,533,095Deferred tax assets
    
    
    115,026
    
    
    
    108,530Total assets
    
    $
    27,095,701
    
    
    $
    11,573,743Liabilities and Shareholders EquityCurrent liabilities:Accounts payable
    
    $
    487,114
    
    
    $
    485,594Current portion  deferred rent
    
    
    35,000
    
    
    
    35,000Income tax payable
    
    
    12,433
    
    
    
    10,000Accrued liabilities:Compensation
    
    
    952,835
    
    
    
    903,057Other
    
    
    264,578
    
    
    
    212,028Total current liabilities
    
    
    1,751,960
    
    
    
    1,645,679Deferred rent  less current portion
    
    
    94,886
    
    
    
    112,500Accrued pension liability
    
    
    556,124
    
    
    
    601,037Total liabilities
    
    
    2,402,970
    
    
    
    2,359,216Total shareholders equity
    
    
    24,692,731
    
    
    
    9,214,527Total liabilities and shareholders equity
    
    $
    27,095,701
    
    
    $
    11,573,743




---



##### 



Six Months EndedSeptember 30,2010
    
    
    2009Cash flows from operating activities:Net loss
    
    $
    (1,851,980
    )
    
    $
    (2,240,434
    )Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization
    
    
    567,576
    
    
    
    567,238Loss on disposal of equipment
    
    
    192
    
    
    
    186Share-based consulting expense
    
    
    8,202
    
    
    
    Share-based compensation expense
    
    
    140,490
    
    
    
    291,462Deferred income taxes
    
    
    (4,925
    )
    
    
    (3,249
    )Deferred rent
    
    
    (17,614
    )
    
    
    (17,462
    )Changes in operating assets and liabilities:Accounts receivable
    
    
    (187,514
    )
    
    
    91,206Inventories
    
    
    (125,674
    )
    
    
    47,499Other current assets and income tax receivable
    
    
    (57,949
    )
    
    
    (102,998
    )Accounts payable
    
    
    1,196
    
    
    
    (185,406
    )Accrued liabilities
    
    
    94,179
    
    
    
    (348,419
    )Accrued pension liability, net and income tax payable
    
    
    (48,246
    )
    
    
    (58,492
    )Net cash used in operating activities
    
    
    (1,482,067
    )
    
    
    (1,958,869
    )Cash flows from investing activities:Proceeds from sale of short-term investments
    
    
    2,500,000
    
    
    
    2,500,000Purchase of short-term investments
    
    
    (5,000,000
    )
    
    
    (2,000,000
    )Purchases of property, plant and equipment
    
    
    (94,506
    )
    
    
    (61,334
    )Purchases of intangible assets
    
    
    (11,300
    )
    
    
    Proceeds from sale of property, plant and equipment
    
    
    
    
    
    
    2,000Net cash (used in) provided by investing activities
    
    
    (2,605,806
    )
    
    
    440,666Cash flows from financing activities:Net proceeds from public offering of common stock
    
    
    14,917,059
    
    
    
    Net proceeds from warrant and option exercise
    
    
    2,275,906
    
    
    
    Net cash provided by financing activities
    
    
    17,192,965
    
    
    
    Effect of exchange rates on cash and cash equivalents
    
    
    (28,674
    )
    
    
    34,771Net increase (decrease) in cash and cash equivalents
    
    
    13,076,418
    
    
    
    (1,483,432
    )Cash and cash equivalents at beginning of period
    
    
    2,311,269
    
    
    
    3,276,299Cash and cash equivalents at end of period
    
    $
    15,387,687
    
    
    $
    1,792,867Supplemental disclosure of cash flow information:Cash paid during the period for interest
    
    $
    
    
    
    $
    6,145Cash received(paid) during the period for income taxes
    
    
    248
    
    
    
    (105,877
    )




---



##### 



Three Months Ended
    
    
    Six Months EndedSeptember 30,
    
    
    September 30,2010
    
    
    2009
    
    
    2010
    
    
    2009Gross ProfitGAAP gross profit
    
    $
    2,650,354
    
    
    $
    2,451,401
    
    
    $
    5,175,157
    
    
    $
    4,725,360% of sales
    
    
    82
    %
    
    
    82
    %
    
    
    82
    %
    
    
    81
    %Share-based compensation
    
    
    4,184
    
    
    
    4,903
    
    
    
    8,667
    
    
    
    18,448Depreciation expense
    
    
    15,766
    
    
    
    14,150
    
    
    
    31,464
    
    
    
    28,299Non-GAAP gross profit
    
    
    2,670,304
    
    
    
    2,470,454
    
    
    
    5,215,288
    
    
    
    4,772,107Operating ExpensesGAAP operating expenses
    
    
    3,597,478
    
    
    
    3,328,495
    
    
    
    7,047,718
    
    
    
    6,973,962Share-based compensation
    
    
    68,241
    
    
    
    113,909
    
    
    
    140,024
    
    
    
    273,014Depreciation expense
    
    
    57,074
    
    
    
    57,546
    
    
    
    114,662
    
    
    
    115,623Amortization expense
    
    
    210,682
    
    
    
    211,503
    
    
    
    421,450
    
    
    
    423,316Non-GAAP operating expenses
    
    
    3,261,481
    
    
    
    2,945,537
    
    
    
    6,371,582
    
    
    
    6,162,009Operating LossGAAP operating loss
    
    
    (947,124
    )
    
    
    (877,094
    )
    
    
    (1,872,561
    )
    
    
    (2,248,602
    )Share-based compensation
    
    
    72,425
    
    
    
    118,812
    
    
    
    148,692
    
    
    
    291,462Depreciation expense
    
    
    72,840
    
    
    
    71,696
    
    
    
    146,126
    
    
    
    143,922Amortization expense
    
    
    210,682
    
    
    
    211,503
    
    
    
    421,450
    
    
    
    423,316Non-GAAP operating loss
    
    $
    (591,177
    )
    
    $
    (475,083
    )
    
    $
    (1,156,293
    )
    
    $
    (1,389,902
    )